Star Wars Sale
 
 

Special Offers see all

Enter to WIN!

Weekly drawing for $100 credit. Subscribe to PowellsBooks.news for a chance to win.
Privacy Policy

More at Powell's


Recently Viewed clear list


The Powell's Playlist | June 18, 2014

Daniel H. Wilson: IMG The Powell’s Playlist: Daniel H. Wilson



Like many writers, I'm constantly haunting coffee shops with a laptop out and my headphones on. I listen to a lot of music while I write, and songs... Continue »
  1. $18.87 Sale Hardcover add to wish list

    Robogenesis

    Daniel H. Wilson 9780385537094

spacer
Qualifying orders ship free.
$6.95
Used Hardcover
Ships in 1 to 3 days
Add to Wishlist
Qty Store Section
1 Burnside Health and Medicine- Politics of Health Care

The Cell Game: Sam Waksal's Fast Money and False Promises--And the Fate of Imclone's Cancer Drug

by

The Cell Game: Sam Waksal's Fast Money and False Promises--And the Fate of Imclone's Cancer Drug Cover

 

Synopses & Reviews

Publisher Comments:

It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its "miracle" cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess.

At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked entrepreneur, Waksal was addicted to the trappings of wealth and fame that accrued to a darling of the stock market and the overheated atmosphere of biotech IPOs. At the height of his stardom, Waksal hobnobbed with Martha Stewart in New York and Carl Icahn in the Hamptons, hosted parties at his fabulous art-filled loft, and was a fixture in the gossip columns. He promised that Erbitux would "change oncology," and would soon be making $1 billion a year.

But as Waksal partied late into the night, desperate cancer patients languished, waiting for his drug to come to market. When the FDA withheld approval of Erbitux, the charming scientist who had always stayed just one step ahead of bankruptcy panicked and desperately tried to cash in his stock before the bad news hit Wall Street.

Waksal is now in jail, the first of the Enron-era white-collar criminals to be sentenced. Yet his cancer drug has proved more durable than his evanescent profits. Erbitux remains promising, the leading example of a new way to fight cancer, and patients and investors hope it will be available soon.

Book News Annotation:

New York-based writer Prud'homme tells how entrepreneur Waksal built a fast-growing biotechnology company, borrowed heavily against the success of its drug Erbitux, tried to bail out when the FDA rejected the drug, and ended up in prison.
Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)

Synopsis:

Beneath the ImClone headlines that shout "Martha Stewart" and "Insider Trading" lies a heartbreaking story of desperate cancer patients waiting in vain for a "miracle" drug that would keep them alive. 8-page photo insert.

About the Author

Alex Prud'homme is a writer living in Brooklyn, New York. His work has appeared in Vanity Fair, The New Yorker, the New York Times, Time, and People.

Product Details

ISBN:
9780060555566
Subtitle:
Sam Waksal's Fast Money and False Promises--and the Fate of ImClone's Cancer Drug
Author:
Prudhomme, Alex
Author:
Prud'homme, Alex
Publisher:
HarperBusiness
Location:
New York
Subject:
Business
Subject:
Drugs
Subject:
Business Ethics
Subject:
Cancer
Subject:
Monoclonal antibodies
Subject:
Businessmen
Subject:
Insider trading in securities
Subject:
Antineoplastic agents industry.
Subject:
Life Sciences - General
Edition Description:
Hardcover
Series Volume:
99/474
Publication Date:
20040120
Binding:
Hardback
Grade Level:
General/trade
Language:
English
Pages:
432
Dimensions:
9 x 6 x 1.33 in 21.97 oz

Other books you might like

  1. The Kite Runner Used Trade Paper $2.50

Related Subjects

Health and Self-Help » Health and Medicine » Politics of Health Care

The Cell Game: Sam Waksal's Fast Money and False Promises--And the Fate of Imclone's Cancer Drug Used Hardcover
0 stars - 0 reviews
$6.95 In Stock
Product details 432 pages HarperBusiness - English 9780060555566 Reviews:
"Synopsis" by , Beneath the ImClone headlines that shout "Martha Stewart" and "Insider Trading" lies a heartbreaking story of desperate cancer patients waiting in vain for a "miracle" drug that would keep them alive. 8-page photo insert.
spacer
spacer
  • back to top
Follow us on...




Powell's City of Books is an independent bookstore in Portland, Oregon, that fills a whole city block with more than a million new, used, and out of print books. Shop those shelves — plus literally millions more books, DVDs, and gifts — here at Powells.com.